SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $57 | -99.9% | 130,400 | +32.9% | 0.01% | +50.0% |
| Q3 2022 | $57,000 | +185.0% | 98,100 | +3.5% | 0.00% | +300.0% |
| Q2 2022 | $20,000 | +11.1% | 94,800 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $18,000 | -85.8% | 93,100 | -2.3% | 0.00% | -66.7% |
| Q4 2021 | $127,000 | -77.0% | 95,300 | -18.6% | 0.00% | -83.3% |
| Q3 2021 | $551,000 | +20.0% | 117,123 | +28.9% | 0.02% | +28.6% |
| Q2 2021 | $459,000 | -21.0% | 90,852 | -21.9% | 0.01% | -54.8% |
| Q1 2021 | $581,000 | +102.4% | 116,358 | -6.2% | 0.03% | +287.5% |
| Q4 2020 | $287,000 | -48.7% | 124,000 | -22.3% | 0.01% | -71.4% |
| Q3 2020 | $559,000 | -1.6% | 159,600 | -33.7% | 0.03% | -9.7% |
| Q2 2020 | $568,000 | +300.0% | 240,700 | +1103.5% | 0.03% | +342.9% |
| Q3 2015 | $142,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
| SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
| Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
| Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
| Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
| Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
| COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
| Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
| SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
| Aristides Capital LLC | 24,302 | $271,000 | 0.19% |